Highbridge Capital Management »

Carmell Therapeutics Corp - US shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $42M 182k 230.00
2023-09-30 $40k 182k 0.22

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
Occidental Pete Corp Warrant (Principal) (OXY.WS)
Ford Mtr Co Del Bond (Principal)
Occidental Pete Corp Option Put Option
Liberty Broadband Corp Common (LBRDK)
Nice Bond (Principal)
Gamida Cell Bond (Principal)
Sarepta Therapeutics Bond (Principal)
Integra Lifesciences Hldgs C Bond (Principal)
Pdd Holdings Bond (Principal)
American Airlines Group Bond (Principal)
Lci Inds Bond (Principal)
Tilray Brands Bond (Principal)
Omnicell Bond (Principal)
Sea Bond (Principal)

View all positions for Highbridge Capital Management

Top funds holding Carmell Therapeutics Corp - US

Balyasny Asset Management
Millennium Management
OZ Management
Highbridge Capital Management
Exos TFP Holdings
CNH Partners
Walleye Trading Advisors
Cowen And Company
Flow Traders US
Saba Capital Management
Whitebox Advisors
Wolverine Asset Management
Ancora Advisors

View all funds holding Carmell Therapeutics Corp - US